These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11279870)

  • 1. Optimal management of dyslipidemia in women and men.
    Haymart MR; Allen J; Blumenthal RS
    J Gend Specif Med; 1999; 2(6):37-42. PubMed ID: 11279870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective review of sex differences in the management of dyslipidemia in coronary heart disease: an analysis of patient data from a Maryland-based health maintenance organization.
    Cooke CE; Hammerash WJ
    Clin Ther; 2006 Apr; 28(4):591-9. PubMed ID: 16750470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women.
    Goldberg AC
    Am J Cardiol; 2004 Jul; 94(1):121-4. PubMed ID: 15219522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women and coronary heart disease risk factors.
    Bittner V
    J Cardiovasc Risk; 2002 Dec; 9(6):315-22. PubMed ID: 12478200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status and management of blood lipids in Greek adults and their relation to socio-demographic, lifestyle and dietary factors: the ATTICA Study. Blood lipids distribution in Greece.
    Panagiotakos DB; Pitsavos C; Chrysohoou C; Skoumas J; Stefanadis C
    Atherosclerosis; 2004 Apr; 173(2):353-61. PubMed ID: 15064113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of cholesterol levels and the prevention of coronary heart disease in women.
    Mosca LJ
    Am Fam Physician; 2002 Jan; 65(2):217-26. PubMed ID: 11820486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS).
    Hammoudeh AJ; Al-Tarawneh H; Elharassis A; Haddad J; Mahadeen Z; Badran N; Izraiq M; Al-Mousa E
    Int J Cardiol; 2006 Jun; 110(2):179-83. PubMed ID: 16233922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol: precursor to many lipid disorders.
    Jones PH
    Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex disparity in the management of dyslipidemia among patients with type 2 diabetes mellitus in a managed care organization.
    Nau DP; Mallya U
    Am J Manag Care; 2005 Feb; 11(2):69-73. PubMed ID: 15726854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI).
    Wassertheil-Smoller S; Shumaker S; Ockene J; Talavera GA; Greenland P; Cochrane B; Robbins J; Aragaki A; Dunbar-Jacob J
    Arch Intern Med; 2004 Feb; 164(3):289-98. PubMed ID: 14769624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events.
    Balbisi EA
    Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure in women.
    Lund LH; Mancini D
    Med Clin North Am; 2004 Sep; 88(5):1321-45, xii. PubMed ID: 15331319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of dyslipidemia in the high-risk patient.
    Stein EA
    Am Heart J; 2002 Dec; 144(6 Suppl):S43-50. PubMed ID: 12486415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematocrit and the risk of coronary heart disease mortality.
    Brown DW; Giles WH; Croft JB
    Am Heart J; 2001 Oct; 142(4):657-63. PubMed ID: 11579356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and treatment of lipid disorders in women.
    Zelis R
    Curr Womens Health Rep; 2003 Apr; 3(2):97-103. PubMed ID: 12628078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.